A

Abingworth Portfolio holdings

AUM $307M
This Quarter Return
+10.38%
1 Year Return
+93.6%
3 Year Return
+207.29%
5 Year Return
+452.78%
10 Year Return
AUM
$130M
AUM Growth
Cap. Flow
+$130M
Cap. Flow %
100%
Top 10 Hldgs %
99.79%
Holding
11
New
11
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 75.27%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
AMRN
1
Amarin Corp
AMRN
$311M
$46.8M 36.03%
+8,087,486
New +$46.8M
PTLA
2
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$30.5M 23.47%
+1,240,917
New +$30.5M
SUPN icon
3
Supernus Pharmaceuticals
SUPN
$2.53B
$23.2M 17.84%
+3,600,000
New +$23.2M
ALNY icon
4
Alnylam Pharmaceuticals
ALNY
$58.5B
$9.69M 7.45%
+313,053
New +$9.69M
ACHV icon
5
Achieve Life Sciences
ACHV
$152M
$5.92M 4.55%
+603,740
New +$5.92M
CEMP
6
DELISTED
Cempra, Inc.
CEMP
$5.59M 4.3%
+714,285
New +$5.59M
ZGNX
7
DELISTED
Zogenix, Inc.
ZGNX
$4.02M 3.09%
+2,335,218
New +$4.02M
ANTH
8
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$1.73M 1.33%
+3,503,956
New +$1.73M
HPTX
9
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
$1.38M 1.06%
+62,500
New +$1.38M
GWPH
10
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$879K 0.68%
+102,200
New +$879K
ZLCS
11
DELISTED
ZALICUS INC COM NEW
ZLCS
$268K 0.21%
+473,800
New +$268K